Business
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABBV, MGTI, ACHC, JT and HTHT
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABBV, MGTI, ACHC, JT and HTHT.
About this update from Mgt Capital Investments, Inc.
[{"type":"text","content":"\nNEW YORK, Nov. 21, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.      \n AbbVie Inc. (NYSE: ABBV) Class Period: October 25, 2013 to September 18, 2018 Lead Plaintiff Deadline: November 20, 2018 The complaint alleges that during the class period AbbVie Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) AbbVie’s strategy to increase the sales growth of its blockbuster drug, HUMIRA, relied in part upon illegal kickbacks and unlawful sales and marketing tactics; (2) such practices would foreseeably lead to heightened scrutiny by State governments and agencies; and (3) as a result, Defendants’ public statements were materially false and misleading at all relevant times. Get additional information about the ABBV lawsuit: http://www.kleinstocklaw.com/pslra-1/abbvie-inc-loss-submission-form?wire=3 MGT Capital Investments Inc. (OTCMKTS: MGTI) Class Period: October 9, 2015 to September 7, 2018 Lead Plaintiff Deadline: November 27, 2018 The lawsuit alleges MGT Capital Investments Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) Defendants were engaged in an illegal pump-and-dump scheme to artificially inflate MGT Capital’s stock price; (2) the \"Scheme Defendants\"--Defendants Ladd, Honig, Stetson, Brauser, O’Rourke, and Groussman--had a history of engaging in illegal conduct in connection with the purchase and sale of securities; (3) the Scheme Defendants were a “group”, pursuant to Section 13 of the Exchange Act; (4) the Scheme Defendants exercised control over the Company; (5) the Company’s acquisition of D-Vasive Inc. was part of Defendants’ illegal pump-and-dump scheme to artificially inflate MGT Capital’s stock price; (6) Defendants’ illicit scheme caused MGT Capital to make false and misleading statements, which would result in governmental and regulatory scrutiny; (7) the scheme would result in the delisting of MGT Capital’s stock from NYSE MKT; and (8) as a result, Defendants’ statements about MGT Capital&#...